# Modality.AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/modality-ai

- Industry: Healthcare
- Headquarters: San Francisco, US
- Website: www.modality.ai
- Total disclosed funding: $2.1M
- Latest round: Seed (Aug 19, 2021)
- Investors on record: 2

## About

Based in California, US, and founded in 2018, Modality.AI, Inc. provides a multimodal system to assess neurological and psychiatric states, both in the clinic and remotely. David Pautler (CTO) and David Suendermann-Oeft (CEO) are the co-founders of the company. In August 2021, Modality.AI, Inc. raised USD 2.1 million in seed funding from Relentless Pursuit Partners and Novalis Biotech.

The company provides an automated, clinically validated, multimodal system to assess neurological and psychiatric states both in-person and remotely, allowing researchers and clinicians to analyse data in near real-time and track treatment response over time. The clinic treats a wide range of conditions, including ALS, Parkinson's disease, depression, schizophrenia, autism, multiple sclerosis, Lyme disease, chronic pain, and others.Modality. AI’s partners include the University of California San Francisco, Manhattan Psychiatric Center, NYU Langone Health, Everything ALS, and others.

The organization plans to use the August 2021 funding to accelerate its commercial pipeline and expedite FDA approval for use in clinical care.

## Funding rounds

- Seed, Aug 19, 2021, $2.1M — Relentless Pursuit Partners, Novalis Biotech

## Investors

- Relentless Pursuit Partners (https://capitalatlas.ai/funds/relentless-pursuit-partners) — Seed
- Novalis Biotech (https://capitalatlas.ai/funds/novalis-biotech) — Seed